top of page
Scientist with Test Tubes_edited_edited.jpg

EFIL turns LIFE around

Revolutionizing Metabolic and Related Disease Treatments

Our Current Focus

EFIL targets metabolic diseases with innovative ACAT inhibitor treatments where traditional therapies fall short.hort.

EFIL BioScience

 

Suite 760, 815 Daewangpangyo-ro, Sujeong-gu, Seongnam, Gyeonggi-do, Republic of Korea 13449 

1330 Avenue of The Americas, STE 23A, New York, NY 10019, United States

Email: media@efilbio.com

​

Copyright ⓒ 2021-2026 EFIL BioScience All rights Reserved.

  • Facebook
  • LinkedIn
bottom of page